Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancer-Reference-Cited by-同舟云学术

Randomized phase II trial of TEGAFIRI (tegafur/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable/recurrent colorectal cancer

Published:2016-04-23 Issue:4 Volume:139 Page:946-954
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Shigeta Kohei¹,Hasegawa Hirotoshi¹,Okabayashi Koji¹,Tsuruta Masashi¹,Ishii Yoshiyuki¹,Endo Takashi¹,Ochiai Hiroki¹,Kondo Takayuki¹,Kitagawa Yuko¹

Affiliation:

1. Department of Surgery; Keio University School of Medicine; 35 Shinano-Machi Shinjuku-Ku Tokyo 160-8582 Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer;Goldberg;J Clin Oncol,2004

2. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

3. Overview of systemic therapy for colorectal cancer;Goodwin;Clin Colon Rectal Surg,2009

4. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial;Yoshino;Lancet Oncol,2012

5. Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial;Yamada;Lancet Oncol,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Tumor-Derived Exosome-Educated Hepatic Stellate Cells Regulate Lactate Metabolism of Hypoxic Colorectal Tumor Cells via the IL-6/STAT3 Pathway to Confer Drug Resistance

;OncoTargets and Therapy;2020-08

2. Colorectal Cancer Chemotherapy during COVID-19 Pandemic;Indian Journal of Medical and Paediatric Oncology;2020-03

3. Incidence of neutropenia induced by chemotherapy in the treatment of colorectal cancer;Revista da Rede de Enfermagem do Nordeste;2019-04-03

4. Phase I/II Study of Preoperative Chemoradiotherapy With TEGAFIRI for Locally Advanced Rectal Cancer;Clinical Colorectal Cancer;2018-09

5. Oral versus intravenous fluoropyrimidines for colorectal cancer;Cochrane Database of Systematic Reviews;2017-07-28